Elicio Therapeutics Inc: B. Riley cuts target price to $8 from $27
ELTX•B. Riley cut its target price for Elicio Therapeutics to $8 from $27.
Related News
Fed's Hammack warns inflation pressures remain tilted to upside
TLT•
EOG Resources names Jeff Hibbard CFO effective Jan. 1, 2027
EOG•
QTREX Quantum FY26 H1 net loss narrows to $6.4 million; revenue rises 438% to $1.55 million
QTEX•
Oracle and Blue Owl slip after Oracle reportedly cites force majeure
ORCL•
Synopsys raised to neutral from underperform by BNP Paribas
SNPS•